Skip to content
Review Open access

STRUCTURE–ACTIVITY RELATIONSHIPS AND FUTURE PROSPECTS OF IMATINIB AND NILOTINIB DERIVATIVES IN BCR::ABL1 TYROSINE KINASE INHIBITION

Oct 2026 · Natural Sciences in the Modern World, Vol. 5, No. 18 (2026) · 0 citations · 4 references

Abstract

Materials and methods. A literature review was conducted based on scientific publications investigating imatinib and nilotinib derivatives. Structural modification strategies, including aromatic and heterocyclic fragment modification, halogen and trifluoromethyl (CF₃) substitution, sp³-rich fragment introduction, hybrid molecule design, and improvement of resistance to drug efflux, were comparatively analyzed. Biochemical kinase inhibition data were distinguished from cellular antiproliferative activity.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.